Clorox’s (CLX) Neutral Rating Reiterated at DA Davidson

Clorox (NYSE:CLX)‘s stock had its “neutral” rating reiterated by equities researchers at DA Davidson in a research report issued on Wednesday, Benzinga reports. They currently have a $162.00 target price on the stock. DA Davidson’s price objective indicates a potential upside of 14.03% from the company’s previous close.

Other analysts also recently issued research reports about the stock. Barclays decreased their price objective on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a report on Wednesday, April 10th. UBS Group lifted their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, February 2nd. Citigroup reduced their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research note on Tuesday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday. Finally, Morgan Stanley restated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a research report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $148.63.

Clorox Stock Down 0.3 %

Shares of CLX stock traded down $0.41 on Wednesday, hitting $142.07. The stock had a trading volume of 424,036 shares, compared to its average volume of 1,203,711. The business has a 50 day moving average of $150.67 and a 200 day moving average of $141.68. The stock has a market cap of $17.63 billion, a price-to-earnings ratio of 225.51, a price-to-earnings-growth ratio of 2.19 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. Clorox has a 12-month low of $114.68 and a 12-month high of $178.21.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter last year, the company posted $0.98 earnings per share. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. As a group, analysts expect that Clorox will post 5.52 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. GHP Investment Advisors Inc. increased its position in Clorox by 1.3% during the 4th quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company’s stock valued at $720,000 after purchasing an additional 66 shares during the period. CIBC Private Wealth Group LLC increased its position in Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after purchasing an additional 66 shares during the period. Toroso Investments LLC increased its position in Clorox by 1.3% during the 1st quarter. Toroso Investments LLC now owns 5,266 shares of the company’s stock valued at $833,000 after purchasing an additional 68 shares during the period. Modera Wealth Management LLC boosted its holdings in shares of Clorox by 1.4% during the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after buying an additional 71 shares in the last quarter. Finally, First National Bank of Mount Dora Trust Investment Services boosted its holdings in shares of Clorox by 3.2% during the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.